Research Updates

Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.

by Myles Starr

Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.

by Jon Kelvey

Researchers share approaches for improving participation among underrepresented groups at AACR conference.

by Thomas Celona

The AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.

by Eric Fitzsimmons

From the Editor-in-Chief

Therapeutic vaccines can stimulate an immune response to cancer.

by William G. Nelson, MD, PhD

Forward Look

Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.

by Tara Haelle

Forward Look

Study suggests incorporating race and ethnicity in age-based breast cancer screening guidelines.

by Darcy Lewis

Forward Look

Hiccups are a common and underreported side effect of some cancer treatments.

by Carolyn Bernhardt

Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.

by Stephen Ornes

Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.

by Kendall K. Morgan